Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06938815 · ClinicalTrials.gov registry record · NA
A Novel Regimen for Treatment and Prevention of Post-Inflammatory Hyperpigmentation in Skin of Color
A NA study of Post-inflammatory Hyperpigmentation, sponsored by Narrows Institute for Biomedical Research.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT06938815 is a NA study of Post-inflammatory Hyperpigmentation that has completed, run by Narrows Institute for Biomedical Research. The registered enrollment target is 10 participants, below the 24-participant average among 3 other Post-inflammatory Hyperpigmentation trials with a reported enrollment target (58% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06938815, a NA study of Post-inflammatory Hyperpigmentation, has completed, sponsored by Narrows Institute for Biomedical Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a single-center, prospective, non-blinded, non-randomized 12 week clinical study to evaluate the efficacy of a SkinCeuticals comprehensive skin care regimen in the reduction of post inflammatory hyperpigmentation (PIH) in skin of color patients. The comprehensive regimen features the Pigment Balancing Peel which combines glycolic acid, lactic acid, kojic acid, vitamin C, and emblica into a treatment that may improve skin discoloration. Participants will supplement the Pigment Balancing Peel with a 11 week regimen that includes the Hydrating B5 Gel, Discoloration Defense, LHA Cleansing Gel, and Brightening UV Defense sunscreen.
Conditions Studied
Interventions
- OTHER Pigment Balancing Peel
- OTHER Discoloration Defense Serum
- OTHER LHA Cleansing Gel
- OTHER Hydrating B5 Gel
- OTHER Daily Brightening Sunscreen
Study Locations (1)
New York
- New York Harbor VA Brooklyn Campus - Brooklyn
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2025-02-28 |
| Est. Completion | 2025-07-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06938815
The ClinicalTrials.gov registry entry for NCT06938815 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 24-participant average among 3 other Post-inflammatory Hyperpigmentation trials with a reported enrollment target (58% lower). The listed sponsor is Narrows Institute for Biomedical Research, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Post-inflammatory Hyperpigmentation appearing as the primary indexed condition, and to 5 interventions - of which Pigment Balancing Peel is the first listed.
NCT06938815 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT06938815 about?
NCT06938815 is a clinical study titled "A Novel Regimen for Treatment and Prevention of Post-Inflammatory Hyperpigmentation in Skin of Color". This is a single-center, prospective, non-blinded, non-randomized 12 week clinical study to evaluate the efficacy of a SkinCeuticals comprehensive skin care regimen in the reduction of post inflammatory hyperpigmentation (PIH) in skin of color patients. The comprehensive regimen features the Pigment...
What is the current status of trial NCT06938815?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2025-02-28. Estimated completion is 2025-07-20.
What conditions does trial NCT06938815 study?
This clinical trial studies the following conditions: Post-inflammatory Hyperpigmentation.
What interventions are being tested in trial NCT06938815?
The interventions under investigation include: Pigment Balancing Peel (OTHER), Discoloration Defense Serum (OTHER), LHA Cleansing Gel (OTHER), Hydrating B5 Gel (OTHER), Daily Brightening Sunscreen (OTHER).
Who is sponsoring clinical trial NCT06938815?
This trial is sponsored by Narrows Institute for Biomedical Research, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06938815 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Post-inflammatory Hyperpigmentation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.